List of Mirna Therapeutics, Inc. patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8071562 MiR-124 regulated genes and pathways as targets for therapeutic intervention	Patent 8071562 was granted and assigned to Mirna Therapeutics, Inc. on December, 2011 by the United States Patent and Trademark Office.		‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	8071562	December 6, 2011
‌ US Patent 9365852 Compositions and methods related to miRNA modulation of neovascularization or angiogenesis	Patent 9365852 was granted and assigned to Mirna Therapeutics, Inc. on June, 2016 by the United States Patent and Trademark Office.	‌ Mirna Therapeutics, Inc.	‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	9365852	June 14, 2016
‌ US Patent 9517245 Sorafenib-microRNA combination therapy for liver cancer	Patent 9517245 was granted and assigned to Mirna Therapeutics, Inc. on December, 2016 by the United States Patent and Trademark Office.	‌ Mirna Therapeutics, Inc.	‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	9517245	December 13, 2016
‌ US Patent 9371526 Synthetic mimics of miR-34	Patent 9371526 was granted and assigned to Mirna Therapeutics, Inc. on June, 2016 by the United States Patent and Trademark Office.	‌ Mirna Therapeutics, Inc.	‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	9371526	June 21, 2016
‌ US Patent 9611478 Synthetic mimics of miR-124	Patent 9611478 was granted and assigned to Mirna Therapeutics, Inc. on April, 2017 by the United States Patent and Trademark Office.	‌ Mirna Therapeutics, Inc.	‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	9611478	April 4, 2017
‌ US Patent 9222085 Synthetic mimics of MIR-124	Patent 9222085 was granted and assigned to Mirna Therapeutics, Inc. on December, 2015 by the United States Patent and Trademark Office.		‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	9222085	December 29, 2015
‌ US Patent 8586727 Synthetic mimics of miR-34	Patent 8586727 was granted and assigned to Mirna Therapeutics, Inc. on November, 2013 by the United States Patent and Trademark Office.		‌ Mirna Therapeutics, Inc.	United States Patent and Trademark Office	8586727	November 19, 2013